The Truth About My Watch List: My 5 Best and Worst Stock Picks
4 extracted signals · 0 resolved · 4 still active
MarketBeatIndependent analyst profile- Source published
- 23 Aug 2026, 22:30 UTC
- Recorded by Tahlil Plus
- 23 Aug 2026, 23:51 UTC

AI-generated source summary
The analysis covers five stocks: SMR, TDUP, DPRO, MU, and NBIS. SMR is identified as a stock with significant decline, but potentially ready for a bottoming pattern, with a target of $15 and a fail bound at $8. TDUP and DPRO are viewed as potential turnaround plays with their own upside targets and defined risk levels. MU and NBIS are presented as stronger bullish plays, with MU showing impressive performance despite past volatility and NBIS having strong analyst support and growth potential in the AI infrastructure sector. MU's recent dip is seen as a buying opportunity for long-term growth, with its supply constraints and strong demand for its HBM4 DRAM expected to drive future performance. NBIS, despite recent price dips, is still showing strong analyst ratings and a positive outlook in the AI sector. The analysis highlights the current market conditions favor stocks that benefit from AI infrastructure build-out and those with strong fundamental performance and analyst support, even amidst broader market volatility.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
4 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
4 signals remain active.
MarketBeat
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.



